GoldenNest Poultry Farms — Executive Summary
GoldenNest Poultry Farms (Pty) Ltd is a proposed commercial layer egg production enterprise to be established in Johannesburg, Gauteng. The Company will produce high-quality, fresh, and food-safe table eggs for distribution to retail chains, restaurants, hotels, food processors, and informal market traders…
Section 1 · Business Plan
Executive Summary
GoldenNest Poultry Farms (Pty) Ltd is a proposed commercial layer egg production enterprise to be established in Johannesburg, Gauteng. The Company will produce high-quality, fresh, and food-safe table eggs for distribution to retail chains, restaurants, hotels, food processors, and informal market traders…
To establish a modern commercial layer egg farm producing ~2.4 million eggs per month, targeting R54.4 million in Year-5 revenue and a 28.4% IRR.
GoldenNest Poultry Farms (Pty) Ltd is a proposed commercial layer egg production enterprise to be established in Johannesburg, Gauteng. The Company will produce high-quality, fresh, and food-safe table eggs for distribution to retail chains, restaurants, hotels, food processors, and informal market traders across the Gauteng Province and, in time, throughout South Africa.
South Africa’s egg market is valued at over R20 billion annually and continues to expand, driven by rising consumer demand for affordable, protein-rich foods; growth in the foodservice and food-processing sectors; and increased consumer focus on product traceability and quality. GoldenNest is positioned to capitalise on these favourable market dynamics through a modern, technology-driven, and biosecure production operation.
1.1 Business Concept
The Company will operate a centralised 50-hectare poultry farm equipped with modern, climate-controlled layer houses, automated feeding and egg collection systems, and integrated waste management and water recycling infrastructure. At full capacity, the farm will house 100,000 commercial layer hens capable of producing approximately 2.4 million eggs per month, equivalent to approximately 80,000 trays of 30 eggs.
GoldenNest will supply the market with conventional caged eggs, barn eggs, and free-range eggs packaged in 6-pack, 12-pack, and 30-tray formats. Additional revenue will be generated through co-branded and private-label packaging arrangements with major retail chains.
1.2 Key Investment Highlights
-
Large and growing addressable market with consistent demand fundamentals
-
Modern, automated production systems ensuring operational efficiency and high biosecurity
-
Experienced and complementary management team with expertise in agriculture, finance, operations, and marketing
-
Attractive unit economics: projected EBITDA margin of approximately 25% from Year 2
-
Clear path to profitability with break-even anticipated within 36 months of commencement
-
Scalable business model with capacity to expand to 250,000 layer hens over five years
-
Alignment with South African government agricultural development and food security priorities
1.3 Financial Summary
The following table summarises the key financial parameters of the investment opportunity:
| Metric | Projection |
| Total Startup Investment Required | R15,000,000 |
| Projected Year 1 Revenue | R27,000,000 |
| Projected Year 2 Revenue (Full Capacity) | R36,000,000 |
| Projected Year 3 Revenue | R41,400,000 |
| Year 2 EBITDA | R9,300,000 |
| Year 2 EBITDA Margin | 25.8% |
| Break-even Period | 36 months |
| Projected 5-Year IRR | 28.4% |
| Projected 5-Year NPV (at 15% discount rate) | R12,600,000 |
1.4 Funding Structure
The Company seeks a total of R15,000,000 in startup capital, structured as follows:
| Funding Source | Amount (ZAR) | Percentage |
| Shareholder Equity | R6,000,000 | 40% |
| Bank / Development Finance Loan | R9,000,000 | 60% |
Debt funding will be sought from commercial banks and/or development finance institutions such as the Land Bank or the Industrial Development Corporation (IDC). Loan repayment is projected over a 7-year term at a blended interest rate of approximately prime + 1.5%.
This document contains proprietary and confidential information. Distribution without written consent is prohibited.